Follow
Hideki Kasuya
Hideki Kasuya
Utsunomiya University
Verified email at snow.ucatv.ne.jp
Title
Cited by
Cited by
Year
Normalized noise energy as an acoustic measure to evaluate pathologic voice
H Kasuya, S Ogawa, K Mashima, S Ebihara
The Journal of the Acoustical Society of America 80 (5), 1329-1334, 1986
3661986
Knowledge, attitudes and practices regarding HIV/AIDS among male high school students in Lao People's Democratic Republic
B Thanavanh, M Harun‐Or‐Rashid, H Kasuya, J Sakamoto
African Journal of Reproduction and Gynaecological Endoscopy 16 (1), 2013
2222013
A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer
A Nakao, H Kasuya, TT Sahin, N Nomura, A Kanzaki, M Misawa, T Shirota, ...
Cancer gene therapy 18 (3), 167-175, 2011
1672011
The current status and future prospects of oncolytic viruses in clinical trials against melanoma, glioma, pancreatic, and breast cancers
IR Eissa, I Bustos-Villalobos, T Ichinose, S Matsumura, Y Naoe, ...
Cancers 10 (10), 356, 2018
1612018
Acoustic analysis of pathological voice: some results of clinical application
M Hirano, S Hibi, T Yoshida, Y Hirade, H Kasuya, Y Kikuchi
Acta oto-laryngologica 105 (5-6), 432-438, 1988
1461988
Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma
S Nomoto, T Kinoshita, K Kato, S Otani, H Kasuya, S Takeda, N Kanazumi, ...
British journal of cancer 97 (9), 1260-1265, 2007
1442007
A Phase I clinical trial of EUS-guided intratumoral injection of the oncolytic virus, HF10 for unresectable locally advanced pancreatic cancer
Y Hirooka, H Kasuya, T Ishikawa, H Kawashima, E Ohno, IB Villalobos, ...
BMC cancer 18, 1-9, 2018
1352018
Constructing a spoken dialogue corpus for studying paralinguistic information in expressive conversation and analyzing its statistical/acoustic characteristics
H Mori, T Satake, M Nakamura, H Kasuya
Speech Communication 53 (1), 36-50, 2011
1152011
An acoustic analysis of pathological voice and its application to the evaluation of laryngeal pathology
H Kasuya, S Ogawa, Y Kikuchi, S Ebihara
Speech communication 5 (2), 171-181, 1986
1151986
The potential of oncolytic virus therapy for pancreatic cancer
H Kasuya, S Takeda, S Nomoto, A Nakao
Cancer Gene Therapy 12 (9), 725-736, 2005
1072005
Prodrug bioactivation and oncolysis of diffuse liver metastases by a herpes simplex virus 1 mutant that expresses the CYP2B1 transgene
TM Pawlik, H Nakamura, JT Mullen, H Kasuya, SS Yoon, ...
Cancer 95 (5), 1171-1181, 2002
1012002
Genomic signature of the natural oncolytic herpes simplex virus HF10 and its therapeutic role in preclinical and clinical trials
IR Eissa, Y Naoe, I Bustos-Villalobos, T Ichinose, M Tanaka, W Zhiwen, ...
Frontiers in oncology 7, 149, 2017
862017
Regulation of herpes simplex virus γ134.5 expression and oncolysis of diffuse liver metastases by Myb34.5
H Nakamura, H Kasuya, JT Mullen, SS Yoon, TM Pawlik, ...
The Journal of clinical investigation 109 (7), 871-882, 2002
812002
Simultaneous estimation of vocal tract and voice source parameters based on an ARX model
W Ding, H Kasuya, S Adachi
IEICE transactions on information and systems 78 (6), 738-743, 1995
801995
Acoustic nature of the whisper
M Matsuda, H Kasuya
Sixth European Conference on Speech Communication and Technology, 1999
681999
Intraperitoneal delivery of hrR3 and ganciclovir prolongs survival in mice with disseminated pancreatic cancer
H Kasuya, Y Nishiyama, S Nomoto, J Hosono, S Takeda, A Nakao
Journal of surgical oncology 72 (3), 136-141, 1999
661999
Impact of novel oncolytic virus HF10 on cellular components of the tumor microenviroment in patients with recurrent breast cancer
TT Sahin, H Kasuya, N Nomura, T Shikano, K Yamamura, T Gewen, ...
Cancer gene therapy 19 (4), 229-237, 2012
642012
Regulation of herpes simplex virus 1 replication using tumor-associated promoters
JT Mullen, H Kasuya, SS Yoon, NM Carroll, TM Pawlik, S Chandrasekhar, ...
Annals of surgery 236 (4), 502-513, 2002
632002
Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis
S Yamada, S Takeda, T Fujii, S Nomoto, N Kanazumi, H Sugimoto, ...
Annals of surgery 246 (2), 254-258, 2007
602007
Suitability of a US3-inactivated HSV mutant (L1BR1) as an oncolytic virus for pancreatic cancer therapy
H Kasuya, Y Nishiyama, S Nomoto, F Goshima, S Takeda, I Watanabe, ...
Cancer gene therapy 14 (6), 533-542, 2007
592007
The system can't perform the operation now. Try again later.
Articles 1–20